Showing results (51-60 of 1,693) with videos related to
Sort By:
Pageof 170
Hepatology (Baltimore, Md.)|March 1, 1992
Treatment of hyperammonemia with carbamylglutamate in ratsE Grau, V Felipo, M D Miñana, et al.Development (Cambridge, England)|March 1, 1995
The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrainA P Monaghan, E Grau, D Bock, et al.Journal of Evolutionary Biology|September 14, 2010
Selection for thermostability can lead to the emergence of mutational robustness in an RNA virusP Domingo-Calap, M Pereira-Gómez, R SanjuánAmerican Journal of Public Health|October 19, 2013
Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban populationHana Akselrod, Lauretta E Grau, Russell Barbour, et al.Trends in Parasitology|February 28, 2012
Antigen presentation by endothelial cells: what role in the pathophysiology of malaria?Romy Razakandrainibe, Stéphane Pelleau, Georges E Grau, et al.Neurochemical Research|October 1, 1992
The susceptibility of MAP-2 to proteolytic degradation increases when bound to tubulinE Grau, V Felipo, M D Miñana, et al.Clinical and Experimental Immunology|January 1, 1990
T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjectsC Chizzolini, G E Grau, A Geinoz, et al.Immunology|January 1, 1990
Role of TNF and IL-1 in infections with Toxoplasma gondiiH R Chang, G E Grau, J C PechèreThe International Journal of Biochemistry & Cell Biology|March 30, 2013
Crossing the wall: the opening of endothelial cell junctions during infectious diseasesRomy Razakandrainibe, Valery Combes, Georges E Grau, et al.Harm Reduction Journal|November 14, 2023
"It's starting to weigh on me": Exploring the Experiences and Support Needs of Harm Reduction Staff in Connecticut using the Social-Ecological ModelKatherine Hill, Katherine Dunham, Lauretta E Grau, et al.Pageof 170